Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ian Hirsch"'
Autor:
Eugene R. Bleecker, Deborah A. Meyers, Dean Billheimer, Huashi Li, Paul Newbold, Justin Kwiatek, Ian Hirsch, Rohit Katial, Xingnan Li
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice.
Autor:
Anne-Marie Rick, Matthew Laurens, Ying Huang, Chenchen Yu, Thomas C. S. Martin, Carina A. Rodriguez, Christina Rostad, Rebone M. Maboa, Lindsey Baden, Hana M. El Sahly, Beatriz Grinsztejn, Glenda Gray, Cynthia L. Gay, Peter B. Gilbert, Holly E. Janes, James G. Kublin, Yunda Huang, Brett Leav, Ian Hirsch, Frank Struyf, Lisa M. Dunkle, Kathleen M. Neuzil, Lawrence Corey, Paul Goepfert, Stephen R. Walsh, Dean Follmann, Karen L. Kotloff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0043ded797d2e3e7abb78cd4ded7a5d7
https://doi.org/10.2139/ssrn.4425340
https://doi.org/10.2139/ssrn.4425340
Autor:
María Paula Pinto, Janeth Lara Alcántara, Johanna Costa, Ian Hirsch, Lucía Piñón, Gabriela Comesaña, Miguel Samec, Patricio Servienti, María L. Ortellado, Laura E. Aranda
Publikováno v:
Oncología Clínica. 26
El cáncer de ovario ocupa el quinto lugar en frecuencia y es la cuarta causa de muerte por cáncer en las mujeres. Según la clasificación de la Organización Mundial de la Salud (OMS), existen diferentes tipos basados en sus características
Autor:
Janeth Lara Alcántara, Patricio Servienti, Gabriela Comesaña, Paula Pinto, Pascual Valdez, Johana Costa, Ian Hirsch, Lucía Piñón
Publikováno v:
Oncología Clínica. 26
En las últimas décadas la incidencia de cáncer ha aumentado. Nuevas técnicas de diagnóstico y nuevos tratamientos han aumentado la supervivencia de los pacientes con cáncer.. Esta supervivencia implica convivir con una enfermedad crónic
Publikováno v:
Nature medicine. 28(11)
Publikováno v:
Nature Medicine. 28:2236-2237
Autor:
Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck, Hong-Van Tieu, Kenneth H. Mayer, Lawrence Corey, Kathleen M. Neuzil, Tina Tong, Margaret Brewinski Isaacs, Holly Janes, Himanshu Bansal, Lindsay M. Edwards, Justin A. Green, Elizabeth J. Kelly, Kathryn Shoemaker, Therese Takas, Tom White, Prakash Bhuyan, Tonya Villafana, and Ian Hirsch
Publikováno v:
The Journal of clinical investigation. 132(18)
BackgroundWe report updated safety, efficacy, and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) from an ongoing phase 3 trial.MethodsAdults at increased risk of SARS-CoV-2 infection were randomized (2:1), stratified by age, to receive 2 doses of AZD122
Autor:
Elizabeth R. Brown, Youyi Fong, Kathleen M. Neuzil, Holly Janes, Shu Han, Peter B. Gilbert, Iksung Cho, Yunda Huang, Michael P. Fay, Lindsay N. Carpp, An Vandebosch, Thomas R. Fleming, Martha Nason, David Benkeser, Marco Carone, Ying Huang, Paula W. Annunziato, Alex Luedtke, Jonathan Hartzel, Ian Hirsch, Deborah Donnell, Michal Juraska, Myron S. Cohen, Honghong Zhou, Devan V. Mehrotra, Ollivier Hyrien, Dean Follmann, Lawrence Corey
Publikováno v:
Annals of Internal Medicine
Safe and effective vaccines are a critical component in the control of COVID-19. A group of industry, government, and academic researchers discuss pragmatic issues in the choice and interpretation of clinical endpoints for evaluating efficacy in COVI
Publikováno v:
Annals of Allergy, Asthma & Immunology. 125:171-176
Background Blood eosinophil count (BEC) measurements are a noninvasive, relatively reliable surrogate marker for eosinophilic airway inflammation. Single measurements of peripheral BEC greater than or equal to 150 cells/μL predict the response to an
Publikováno v:
Annals of Allergy, Asthma & Immunology. 124:79-86
Background Fixed airflow obstruction (FAO) is associated with severe eosinophilic asthma. Benralizumab is an interleukin-5 receptor alpha–directed cytolytic monoclonal antibody for patients with severe, uncontrolled eosinophilic asthma. Objective W